Biological and functional characteristics of a novel lowmolecular weight antagonist of glucose-dependent insulinotropic polypeptide receptor, SKL-14959, iin vitro/i and iin vivo/i

Diabetes, Obesity and Metabolism, 05/11/2012

These data indicate that SKL–14959 is distinguished in the physiological phenotype of glucose–dependent insulinotropic polypeptide (GIP) following direct binding to the receptor.

Print Article Summary Cat 2 CME Report